源语言 | 英语 |
---|---|
页(从-至) | 641-648 |
页数 | 8 |
期刊 | Value in Health |
卷 | 12 |
期 | 5 |
DOI | |
出版状态 | 已出版 - 2009 |
!!!ASJC Scopus Subject Areas
- 公共卫生、环境和职业健康
- 卫生政策
指纹
探究 'The cost-utility of sequential adjuvant trastuzumab in women with Her2/Neu-Positive Breast Cancer: An analysis based on updated results from the HERA trial' 的科研主题。它们共同构成独一无二的指纹。引用此
Skedgel, C., Rayson, D., & Younis, T. (2009). The cost-utility of sequential adjuvant trastuzumab in women with Her2/Neu-Positive Breast Cancer: An analysis based on updated results from the HERA trial. Value in Health, 12(5), 641-648. https://doi.org/10.1111/j.1524-4733.2009.00511.x